Ray Dalio Avanos Medical, Inc. Transaction History
Bridgewater Associates, LP
- $19.6 Billion
- Q1 2024
A detailed history of Ray Dalio (Bridgewater Associates, LP) transactions in Avanos Medical, Inc. stock. As of the latest transaction made, Bridgewater Associates, LP holds 17,261 shares of AVNS stock, worth $343,666. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,261
Previous 32,790
47.36%
Holding current value
$343,666
Previous $735,000
53.33%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding AVNS
# of Institutions
275Shares Held
42.8MCall Options Held
19.4KPut Options Held
17.6K-
Black Rock Inc. New York, NY7.26MShares$145 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.4MShares$107 Million0.0% of portfolio
-
Rgm Capital, LLC Naples, FL3.17MShares$63.1 Million2.53% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.68MShares$53.4 Million0.01% of portfolio
-
Westwood Holdings Group Inc Dallas, TX2.11MShares$42.1 Million0.33% of portfolio
About AVANOS MEDICAL, INC.
- Ticker AVNS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 46,487,000
- Market Cap $926M
- Description
- Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, ...